Viking Therapeutics (VKTX) Current Leases (2019 - 2025)
Historic Current Leases for Viking Therapeutics (VKTX) over the last 7 years, with Q4 2025 value amounting to $137000.0.
- Viking Therapeutics' Current Leases fell 7198.36% to $137000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $137000.0, marking a year-over-year decrease of 7198.36%. This contributed to the annual value of $137000.0 for FY2025, which is 7198.36% down from last year.
- Latest data reveals that Viking Therapeutics reported Current Leases of $137000.0 as of Q4 2025, which was down 7198.36% from $437000.0 recorded in Q3 2025.
- Over the past 5 years, Viking Therapeutics' Current Leases peaked at $498000.0 during Q1 2025, and registered a low of $29000.0 during Q4 2021.
- For the 5-year period, Viking Therapeutics' Current Leases averaged around $302500.0, with its median value being $311500.0 (2023).
- In the last 5 years, Viking Therapeutics' Current Leases tumbled by 9121.21% in 2021 and then soared by 94827.59% in 2022.
- Viking Therapeutics' Current Leases (Quarter) stood at $29000.0 in 2021, then soared by 948.28% to $304000.0 in 2022, then increased by 6.58% to $324000.0 in 2023, then surged by 50.93% to $489000.0 in 2024, then plummeted by 71.98% to $137000.0 in 2025.
- Its Current Leases was $137000.0 in Q4 2025, compared to $437000.0 in Q3 2025 and $468000.0 in Q2 2025.